An Inbook in the American Journal of Accountable Care: Iron Supplementation in the Management of Heart Failure: Optimizing Outcomes and Resource Utilization

An Inbook in the American Journal of Accountable Care: Iron Supplementation in the Management of Heart Failure: Optimizing Outcomes and Resource Utilization is organized by Pharmacy Times Continuing Education (PTCE).,Release date: August 29, 2022,Expiration date: August 29, 2023,Description:,Iron deficiency (ID) and iron deficiency anemia (IDA) are common comorbidities in patients with heart failure. Intravenous (IV) iron therapy has been recommended by leading heart failure guidelines over the use of oral iron supplementation in patients with ID and IDA. This article will review the efficacy and safety data of IV iron, with attention to the patient-reported quality of life impact. With no IV iron formulation currently preferred in the US guidelines, understanding clinical features and evidence for available IV iron products in the treatment of ID and IDA for patients with heart failure is imperative for individuals involved in formulary decision-making. To encourage the use of IV iron in patients with heart failure and ID or IDA, managed care professionals can develop treatment pathways and implement formulary strategies that make IV iron available to patients. This activity will additionally examine strategies to reduce barriers to access and improve treatment approaches to reduce healthcare costs associated with ID and IDA in heart failure.,Educational Objectives:,At the completion of this activity, participants will be able to:,• Examine the clinical presentation and lab values that indicate the presence of iron deficiency (ID) and iron deficiency anemia (IDA) in patients with heart failure, including its underlying pathophysiology.,• Differentiate the treatment approaches for patients with heart failure with ID/IDA under European and US guidelines, including recent clinical trial data supporting the use of intravenous (IV) iron.,• Analyze the costs of IV iron therapy and the burden of illness in context with the total healthcare resource utilization required by patients with heart failure with ID/IDA.,• Optimize the managed care role in the care of patients with heart failure with ID/IDA to improve patient outcomes and support the rational allocation of healthcare resources.